C. difficile Papers
@Cdiff_Papers
Latest from the Clostridium difficile research community. Edited by @nataszahain
You might like
A new antimicrobial peptide designed based on Clostridioides difficile IF1 shows broad-spectrum inhibitory activities against C. difficile and other bacterial strains. journals.asm.org/doi/10.1128/sp…
In @CIDJournal, Pablo Okhuysen, MD, FACP, FIDSA, and colleagues aim to confirm the superiority of ridinilazole over vancomycin on Sustained Clinical Response and recurrent CDI as reported in a Phase II Study. Read: idsajournals.link/2OufYh
Friday Celebrations! Chenlin Hu, PhD and @GareyKgarey published a review of microscopy methods for C. difficile in Anaerobe! 🔬🦠 Check it out ⬇️⬇️ doi.org/10.1016/j.anae… @AnaerobeSociety @UH_Pharmacy
🌟And the publications keep coming!🌟 Check out our labs most recent work on ibezapolstat activity against MDR C. difficile strains ⬇️⬇️ doi.org/10.1128/aac.01… TLDR: IBZ bactericidal activity was similar to the MIC and maintained in wild-type and non-susceptible strains.
🆕️🔥Multicenter cohort study included adults with C. difficile infection @CIDJournal Vancomycin MIC >2 μg/mL in Clostridioides difficile was associated with decreased odds of 30-day sustained clinical response & lower 14-day initial cure rates #IDXposts academic.oup.com/cid/article-ab…
It's not just about age anymore. #Clostridioidesdifficile infection is reaching beyond traditional risk groups. #guthealth #Cdiff
Clindamycin attacking the normal flora 🥊
Pleased to share this publication on vaccine potential of Salmonella against C. difficile in a mouse model: a collaboration with Brian Ward and Ph. D. student Kaitlin Winter @MIMM_McGill and my group @inrsciences @infectiopole. Out in Microbiol. Spectrum: journals.asm.org/doi/10.1128/sp…
Have you seen this new @AmCollegeGastro monograph on microbiome therapeutics? ✅ Essential aspects of methods for analyzing the microbiome ✅ Present and future therapeutics for C. difficile ✅ Non-prescription therapeutics 👉 journals.lww.com/ajg/toc/2024/0…
New findings shed light on the key #microbes that protect against recurrent #Clostridiodes difficile infection and #MultipleSclerosis, pointing to future treatment opportunities with live #biotherapeutics. Read more: mshs.co/3Q9ZZdH #Immunology
Happy to share the latest preprint from the @StadtmuellerLab - an incredible effort by recent PhD student @Sonya31397350! Engineered Secretory Immunoglobulin A provides insights on antibody-based effector mechanisms targeting Clostridiodes difficile biorxiv.org/content/10.110…
Fecal Microbiota Transplantation: Information for the Pediatrician publications.aap.org/pediatrics/art…
publications.aap.org
Fecal Microbiota Transplantation: Information for the Pediatrician
Fecal microbiota transplantation (FMT) involves the delivery of an entire microbial community from a healthy donor to a recipient with the intention of ameliorating or curing a specific disease....
Genetic variation in the human leukocyte antigen region confers susceptibility to Clostridioides difficile infection nature.com/articles/s4159…
Update on Microbiota-derived therapies for recurrent Clostridioides difficile infections, 2023 sciencedirect.com/science/articl…
C. Diff: Professors Suggest Inflammation, Not Bacteria Should be Targeted bit.ly/4akb9UH #CDiff #ClostridioidesDifficile
Grat to Jannie and CMAT for this study on bacterial and fungal microbiome interactions in patients colonized or infected with Cdiff. @EurFmt @CMIJournal @SmitsLab oaepublish.com/articles/mrr.2…
The role of gut fungi in #Clostridioides difficile infection sciencedirect.com/science/articl… #OpenAccess #mycology #Cdiff
🆕🔥Our study on C. difficile infections among allogeneic HCT recipients in the framework of the Swiss Transplant Cohort Study🇨🇭@BMTjournal @TheEBMT A short summary 🔽1/5 #IDTwitter nature.com/articles/s4140…
Doxycycline tied to lower risk for C. difficile in pneumonia patients medicalxpress.com/news/2023-11-d…
Could a Breath biopsy be used for C. difficile diagnosis in the future? Breath Biopsy and Discovery of Exclusive Volatile Organic Compounds for Diagnosis of Infectious Diseases ncbi.nlm.nih.gov/pmc/articles/P…
United States Trends
- 1. Rams 20.6K posts
- 2. Seahawks 26.4K posts
- 3. 49ers 18.5K posts
- 4. Lions 67.2K posts
- 5. Commanders 69.2K posts
- 6. Niners 4,440 posts
- 7. Bills 141K posts
- 8. Giants 70.2K posts
- 9. Stafford 6,473 posts
- 10. Cardinals 9,952 posts
- 11. Canada Dry 1,008 posts
- 12. Dan Campbell 2,534 posts
- 13. #OnePride 3,971 posts
- 14. Daboll 14.1K posts
- 15. Jags 7,447 posts
- 16. Bears 63K posts
- 17. #RaiseHail 3,090 posts
- 18. Dart 28.1K posts
- 19. Gibbs 6,948 posts
- 20. Caleb 51.8K posts
You might like
-
Ed Kuijper
@EdKuijper2 -
Wiep Klaas Smits
@SmitsLab -
Joe Sorg
@thejoesorg -
Joe Zackular
@joeyzacks -
Daniel Paredes-Sabja
@DParedesSabja -
Britton Lab
@BrittonTML -
Fagan Lab at the University of Sheffield
@RobFagan -
MayoClinicHealthSystem
@MayoClinicHS -
The Seeker
@TheSeeker268 -
Columbia Epidemiology
@CUEpidemiology
Something went wrong.
Something went wrong.